BLISS GVS PHARMA
Back to Cashflow Statement
|
BLISS GVS PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹152 Cr | ₹34 Cr | ₹135 Cr | ₹64 Cr | ₹47 Cr |
What is the latest Cash Flow from Operating Activities ratio of BLISS GVS PHARMA ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹152 Cr |
Mar2023 | ₹34 Cr |
Mar2022 | ₹135 Cr |
Mar2021 | ₹64 Cr |
Mar2020 | ₹47 Cr |
How is Cash Flow from Operating Activities of BLISS GVS PHARMA Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹152 Cr | 344.28 | |
Mar2023 | ₹34 Cr | -74.67 | |
Mar2022 | ₹135 Cr | 111.79 | |
Mar2021 | ₹64 Cr | 36.97 | |
Mar2020 | ₹47 Cr | - |
Compare Cash Flow from Operating Activities of peers of BLISS GVS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BLISS GVS PHARMA | ₹1,457.2 Cr | -6.1% | 9.6% | 30.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹399,249.0 Cr | -1.3% | -3.3% | 8.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,940.0 Cr | -1.5% | 0.8% | 42.3% | Stock Analytics | |
CIPLA | ₹121,197.0 Cr | -1.7% | 2.3% | -5.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,618.0 Cr | -1.6% | 8.4% | 10.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,250.0 Cr | -3.3% | -1.4% | 9.8% | Stock Analytics |
BLISS GVS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BLISS GVS PHARMA | -6.1% |
9.6% |
30.3% |
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses